RR

Rajaram Ramesh

Director Director DIN 06368621
DIN 06368621 First appointment Sep 2012 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajaram Ramesh

Data last updated:

Rajaram Ramesh was a Director at Shivagiri Medical Research Foundation Private Limited (2012–2013) and Director at Bientot Builders Private Limited (from 2012). The companies operate in Healthcare.

DIN 06368621
Primary Designation Director
Industry Healthcare
First Appointment 03 Sep 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Sep 20122012Strike Off
Bientot Builders Private Limited U45208TN2012PTC087912
Director03 Oct 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bientot Builders Private Limited
Shivagiri Medical Research Foundation Private Limited
Premium access

Shareholding and investment profile for Rajaram Ramesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajaram Ramesh

Rajaram Ramesh was first appointed on 03 Sep 2012 as Director at Shivagiri Medical Research Foundation Private Limited.

Rajaram Ramesh held 2 earlier board appointments: Shivagiri Medical Research Foundation Private Limited (Director, 03 Sep 2012 to 17 Sep 2013); Bientot Builders Private Limited (Director, from 03 Oct 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available